logo
Share SHARE
FONT-SIZE Plus   Neg

Mylan, Pfizer To Settle Litigation Relating To Detrol - Quick Facts

Mylan Inc. (MYL: Quote) announced that the company and its subsidiary, Mylan Pharmaceuticals Inc., inked a settlement agreement with Pfizer Inc. (PFE: Quote), Pharmacia & Upjohn Co. LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application, or ANDA, for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

As per the terms of the settlement agreement, Mylan may start selling the product on January 1, 2014, or earlier under certain limited circumstances, and no later than March 1, 2014, subject to final approval from the U.S. Food and Drug Administration. Under the terms of the agreement, Mylan may launch the product as either an authorized generic or under its own ANDA. Pursuant to the agreement, the pending litigation will be dismissed.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A new study reveals that more large companies in the U.S. are run by men with the names John, Robert, William or James than the total number of women CEOs. For each women CEO of S&P 1500 companies there are four men CEOs named John, Robert, William or James, according to a study conducted by the New... Ahead of the Ferrari IPO this year, Fiat Chrysler Automobiles said it would sell more than the 10 percent stake it initially planned in the luxury car division's public debut as investor sentiment brightens and the need to stabilize stock prices gains importance. In a thumbs up for the Iceland bond market, investors strongly oversubscribed to a bench-marked bond offering by Arion Bank, as the Nordic island country warms up to possible easy access to international credit. Arion Bank issued bonds for 300 million euros and received bids of more than 675 million euros from about 100 investors. The bonds are 3-year instruments with a fixed 3.125 percent coupon.
comments powered by Disqus
RELATED NEWS
Trade MYL now with 
Follow RTT